Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Should African Americans have a lower blood pressure goal than other ethnic groups to prevent organ damage?

Flack JM, Okwuosa T, Sudhakar R, Ference B, Levy P.

Curr Cardiol Rep. 2012 Dec;14(6):660-6. doi: 10.1007/s11886-012-0314-6.

PMID:
23065361
2.

Should African Americans with hypertension be treated differently than non-African Americans?

Flack JM, Ference BA, Levy P.

Curr Hypertens Rep. 2014 Jan;16(1):409. doi: 10.1007/s11906-013-0409-5. Review.

PMID:
24370966
3.
4.

Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes.

Flack JM, Hamaty M.

J Hypertens Suppl. 1999 Feb;17(1):S19-24. Review.

PMID:
10340840
5.

Hypertension and kidney disease: what do the data really show?

Cohen DL, Townsend RR.

Curr Hypertens Rep. 2012 Oct;14(5):462-7. doi: 10.1007/s11906-012-0285-4. Review.

PMID:
22814743
6.

Recommendations for the management of special populations: racial and ethnic populations.

Ferdinand KC.

Am J Hypertens. 2003 Nov;16(11 Pt 2):50S-54S. Review.

PMID:
14625162
7.

Awareness, treatment, and control of vascular risk factors in African Americans with stroke.

Ruland S, Raman R, Chaturvedi S, Leurgans S, Gorelick PB; AAASPS Investigators. African American Antiplatelet Stroke Prevention Study.

Neurology. 2003 Jan 14;60(1):64-8.

PMID:
12525719
8.

The management of hypertension in African Americans.

Ferdinand KC, Armani AM.

Crit Pathw Cardiol. 2007 Jun;6(2):67-71. Review.

PMID:
17667868
9.

Hypertension-related morbidity and mortality in African Americans--why we need to do better.

Ferdinand KC, Saunders E.

J Clin Hypertens (Greenwich). 2006 Jan;8(1 Suppl 1):21-30. Review.

10.

Hypertension: trends, risks, drug therapies and clinical challenges in African Americans.

Hollar D, Agatston AS, Hennekens CH.

Ethn Dis. 2004 Autumn;14(4):S2-23-5. Review.

PMID:
15724793
11.

Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.

Kaperonis N, Bakris G.

Curr Opin Nephrol Hypertens. 2003 Jan;12(1):79-84. Review.

PMID:
12496670
12.

Epidemiology of hypertension and cardiovascular disease in African Americans.

Flack JM, Ferdinand KC, Nasser SA.

J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1 Suppl 1):5-11.

13.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
14.

Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Parati G, Ochoa JE, Bilo G.

Curr Hypertens Rep. 2012 Oct;14(5):421-31. doi: 10.1007/s11906-012-0290-7. Review.

PMID:
22903810
15.
16.

Current treatment of patients with hypertension: therapeutic implications of INSIGHT.

Taddei S, Ghiadoni L, Salvetti A.

Drugs. 2003;63(14):1435-44. Review.

PMID:
12834362
17.
18.

Predictors of participant adherence and retention in the African American Study of Kidney Disease and Hypertension.

Brooks D, Charleston J, Dowie D, Gabriel A, Hall YB, Hiremath L, Lightfoot T, Sika M, Smith WC, Wang X.

Nephrol Nurs J. 2008 Mar-Apr;35(2):133-42.

PMID:
18472682
19.

Therapy of hypertension in African Americans.

Flack JM, Nasser SA, Levy PD.

Am J Cardiovasc Drugs. 2011;11(2):83-92. doi: 10.2165/11586930-000000000-00000. Review.

PMID:
21446775
20.

Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA).

Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, Jinagouda S, Shea S.

Am J Hypertens. 2004 Oct;17(10):963-70.

PMID:
15485761
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk